MetLife, Inc.
MET
$69.19
$1.221.80%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.38B | 3.84B | 4.29B | 4.50B | 4.43B |
| Total Depreciation and Amortization | 753.00M | 710.00M | 712.00M | 714.00M | 714.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.58B | 8.71B | 8.86B | 9.95B | 8.09B |
| Change in Net Operating Assets | 5.38B | 1.37B | 1.37B | 1.37B | 1.37B |
| Cash from Operations | 17.09B | 14.63B | 15.23B | 16.53B | 14.60B |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -738.00M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.87B | -16.69B | -13.83B | -12.19B | -11.49B |
| Cash from Investing | -15.61B | -16.69B | -13.83B | -12.19B | -11.49B |
| Total Debt Issued | 2.18B | 2.25B | 2.15B | 2.39B | 1.85B |
| Total Debt Repaid | -2.77B | -1.91B | -2.22B | -3.43B | -3.08B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.88B | -2.83B | -3.10B | -3.45B | -3.21B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -1.00B | -1.00B | -- | -- | -- |
| Total Dividends Paid | -1.70B | -1.71B | -1.71B | -1.72B | -1.73B |
| Other Financing Activities | 6.34B | 5.84B | 4.89B | 3.56B | 3.03B |
| Cash from Financing | 163.00M | 642.00M | 4.00M | -2.65B | -3.13B |
| Foreign Exchange rate Adjustments | 316.00M | -116.00M | -12.00M | -208.00M | -545.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.96B | -1.53B | 1.39B | 1.49B | -571.00M |